No Picture
News

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)– #Biosynthesis–CB Therapeutics achieved the successful biosynthesis of psilocybin, psilocin and related tryptamine-based compounds and filed a patent on the process. […]

No Picture
News

Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer?s Disease at the Clinical Trials in Alzheimer?s Disease (CTAD) Conference

SAN CARLOS, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) — Alkahest Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases, today announced an oral presentation of data fro… […]